<PAGE>
================================================================================
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 10-KSB/A-1
(Mark One)
|X| ANNUAL REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the fiscal year ended December 31,1996
----------------
OR
[ ] TRANSITION REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from ___________________ to ______________________
Commission file number 0-24640
-------
COMMUNITY MEDICAL TRANSPORT, INC.
- --------------------------------------------------------------------------------
(Exact name of small business issuer in its charter)
Delaware 13-3507464
------------------------------- ------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
45 Morris Street, Yonkers, New York 10705
- ------------------------------------------ ----------
(Address of principal executive offices) (Zip Code)
Issuer's telephone number 914-963-6666
------------
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which registered
------------------- -----------------------------------------
_____________________ ________________________________________
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 par value
- --------------------------------------------------------------------------------
(Title of Class)
Redeemable Warrants expiring on September 29, 1999
- --------------------------------------------------------------------------------
(Title of Class)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12
months (or for such shorter period that the issuer was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. Yes....X..... No........
Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B contained herein, and no disclosure will be contained, to
the best of issuer's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB. [ ]
----------
Issuer's revenues for the year ended December 31, 1996 are $15,532,000.
The aggregate market value of the voting stock held by nonaffiliates of the
issuer is $11,066,319 (as of March 25, 1997). The number of shares
outstanding of the issuer's common stock is 4,965,226 (as of March 25,
1997).
DOCUMENTS INCORPORATED BY REFERENCE
Transitional Small Business Disclosure Format: Yes....... No...X....
================================================================================
<PAGE>
Item 13. Exhibits and Reports on Form 8-K
a) Exhibits
3.01 -- Restated Certificate of Incorporation of the Company.(1)
3.02 -- Amended and Restated By-Laws of the Company.(1)
4.01 -- Specimen Certificate representing the Common Stock, par value
$.001 per share.(1)
10.01 -- Employee Stock Option Plan.*(1)
10.02 -- Form of Employee Stock Option Agreement.*(1)
10.03 -- Directors' Stock Option Plan.(1)
10.04 -- Form of Director Stock Option Agreement.(1)
10.05 -- Employment Agreement entered into between the Company and
Dean L. Sloane.*(1)
10.06 -- Form of Employment Agreement entered into between the
Registrant and Craig V. Sloane.*(1)
10.07 -- Lease dated November 29, 1993 by and between D.S.
Corporation and 45 Morris Street Corporation.(1)
10.08 -- Indemnification Agreement entered into between the Company
and each of its directors.(1)
10.09+ -- Agreement dated as of January, 1994 between the Company and
Beth Abraham Hospital.(1)
10.10+ -- Agreement dated as of January 1, 1994 between the Company
and Beth Abraham Hospital.(1).
10.11(i) -- Warrants to purchase 30,000 shares issued to the Equity Group
exercisable immediately.(2)
(ii) -- Warrant to purchase 30,000 shares issued to the Equity Group
exercisable November 1995.(2)
10.12 -- Asset Purchase Agreement dated September 25,1995 between
the Company and Medical Transportation Corporation (3)
10.13 -- Credit Agreement, dated as of December 18, 1996, among the
Company, Atlantic Bank of New York, Fleet Bank, N.A. and
Israel Discount Bank of New York, including collateral
documents.(4)
21.01 -- Subsidiaries of the Company.(1)
23.01 -- Consent of Richard A. Eisner & Company, LLP
27.01 -- Financial Data Schedule
1
<PAGE>
- -------------
+Confidential treatment has been requested for the deleted portion of this
document.
*Management contract or compensatory plan or arrangement.
(1) Such Exhibits were filed with the Company's Registration Statement (File
No. 33-80338) declared effective September 30, 1994 and are incorporated
herein by reference.
(2) Such Exhibits were filed with the Company's Annual Report on Form 10-KSB
for the fiscal year ended December 31, 1994 and are incorporated herein by
reference.
(3) Such Exhibit was filed with the Company's Current Report on Form 8-K, dated
November 1, 1995, and is incorporated herein by reference.
(4) Such Exhibit was previously filed with this Annual Report on Form 10-KSB
for the fiscal year ended December 31, 1996.
(b) Reports on Form 8-K
None
2
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
COMMUNITY MEDICAL TRANSPORT, INC.
By:/s/ Donald J. Panos
----------------------------------
Donald J. Panos
Vice President of Finance
Date: May 9, 1997
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> DEC-31-1996
<CASH> 1,037,000
<SECURITIES> 1,733,000
<RECEIVABLES> 5,405,000
<ALLOWANCES> 334,000
<INVENTORY> 0
<CURRENT-ASSETS> 9,535,000
<PP&E> 4,379,000
<DEPRECIATION> 1,332,000
<TOTAL-ASSETS> 23,016,000
<CURRENT-LIABILITIES> 4,551,000
<BONDS> 0
0
0
<COMMON> 5,000
<OTHER-SE> 12,322,000
<TOTAL-LIABILITY-AND-EQUITY> 23,016,000
<SALES> 0
<TOTAL-REVENUES> 15,532,000
<CGS> 0
<TOTAL-COSTS> 9,819,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 323,000
<INCOME-PRETAX> 692,000
<INCOME-TAX> 298,000
<INCOME-CONTINUING> 394,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 394,000
<EPS-PRIMARY> .10
<EPS-DILUTED> .10
</TABLE>
